Activist 13D/13G Filings - Freeline Therapeutics Holdings plc (FRLN)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, Next
Reported
DateTime		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportFiling
2024-02-22
4:06 pm
Purchase		13DFREELINE THERAPEUTICS HLDGS
FRLN		Syncona Portfolio Ltd65,872,764
100%		28,010,632increase
(+73.98%)		View
2024-02-14
12:15 pm
Unchanged		13GFREELINE THERAPEUTICS HLDGS
FRLN		EVENTIDE ASSET MANAGEMENT LLC0
0%		0
(Unchanged)		View
2024-02-12
4:24 pm
Sale		13GFREELINE THERAPEUTICS HLDGS
FRLN		INTEGRATED CORE STRATEGIES (US) LLC0
0%		-5,555,085decrease
(Position Closed)		View
2024-01-31
4:10 pm
Purchase		13GFREELINE THERAPEUTICS HLDGS
FRLN		Tetragon Financial Management LP6,375,000
9.8%		6,375,000increase
(New Position)		View
2023-11-24
07:30 am
Unchanged		13DFREELINE THERAPEUTICS HLDGS
FRLN		Syncona Portfolio Ltd37,862,132
57.9%		0
(Unchanged)		View
2023-10-18
06:04 am
Purchase		13DFREELINE THERAPEUTICS HLDGS
FRLN		Syncona Portfolio Ltd37,862,132
57.92%		37,862,132increase
(New Position)		View
2023-07-17
4:50 pm
Purchase		13GFREELINE THERAPEUTICS HLDGS
FRLN		INTEGRATED CORE STRATEGIES (US) LLC5,555,085
8.5%		5,555,085increase
(New Position)		View
2023-02-14
1:54 pm
Purchase		13GFREELINE THERAPEUTICS HLDGS
FRLN		EVENTIDE ASSET MANAGEMENT LLC5,920,765
9.1%		2,435,109increase
(+69.86%)		View
2023-02-13
12:01 pm
Purchase		13GFREELINE THERAPEUTICS HLDGS
FRLN		CHI Advisors LLC4,814,419
7.41%		2,938,030increase
(+156.58%)		View
2023-01-31
4:15 pm
Purchase		13GFREELINE THERAPEUTICS HLDGS
FRLN		Tetragon Financial Management LP4,000,000
6.2%		300,000increase
(+8.11%)		View
2022-03-25
4:07 pm
Purchase		13DFREELINE THERAPEUTICS HLDGS
FRLN		Syncona Portfolio Ltd37,862,147
62.27%		19,047,620increase
(+101.24%)		View
2022-03-21
11:10 am
Purchase		13GFREELINE THERAPEUTICS HLDGS
FRLN		Tetragon Financial Management LP3,700,000
6.1%		3,700,000increase
(New Position)		View
2022-02-14
11:47 am
Purchase		13GFREELINE THERAPEUTICS HLDGS
FRLN		EVENTIDE ASSET MANAGEMENT LLC3,485,656
9.7%		1,000,000increase
(+40.23%)		View
2022-02-11
1:00 pm
Purchase		13GFREELINE THERAPEUTICS HLDGS
FRLN		CHI Advisors LLC1,876,389
5.24%		1,876,389increase
(New Position)		View
2022-02-11
12:20 pm
Unchanged		13GFREELINE THERAPEUTICS HLDGS
FRLN		Syncona Portfolio Ltd18,814,527
52.5%		0
(Unchanged)		View
2022-02-04
09:06 am
Sale		13GFREELINE THERAPEUTICS HLDGS
FRLN		WELLINGTON MANAGEMENT GROUP LLP439,795
1.23%		-1,374,189decrease
(-75.76%)		View
2021-11-02
4:32 pm
Sale		13GFREELINE THERAPEUTICS HLDGS
FRLN		Novo Holdings A/S1,785,563
4.99%		-575,666decrease
(-24.38%)		View
2021-08-10
07:57 am
Sale		13GFREELINE THERAPEUTICS HLDGS
FRLN		WELLINGTON MANAGEMENT GROUP LLP1,813,984
5.06%		-1,707,602decrease
(-48.49%)		View
2021-02-12
4:07 pm
Purchase		13GFREELINE THERAPEUTICS HLDGS
FRLN		EVENTIDE ASSET MANAGEMENT LLC2,485,656
7.5%		2,485,656increase
(New Position)		View
2021-02-12
11:04 am
Purchase		13GFREELINE THERAPEUTICS HLDGS
FRLN		Syncona Portfolio Ltd18,814,527
54.2%		18,814,527increase
(New Position)		View
Goto 0, 1, Next